Skip to main content
Clinical Trials/IRCT2017020632402N1
IRCT2017020632402N1
Completed
Phase 3

A Controlled clinical trial to compare the effet of Montelukast and placeboo on disease symptoms and process among 45-15 year old patients with mild to moderate acne

Vice Chancellor for research, Tehran University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acne.
Sponsor
Vice Chancellor for research, Tehran University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for research, Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with acne; being at the age of 15\-45 years old; using antibiotic and other acne treatments for less than 3 months. Exclusion criteria: age under 14 year\-old and older than 45 year\-old; indication for systemic retinoid treatment; nodulocystic acne (with scar formation possibility); antibiotic treatment for more than 3 months; Hormonal related acne(polycystic ovarian disease)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials